Alfuzosin
Brand names,
Alfuzosin
Analogs
Alfuzosin
Brand Names Mixture
Alfuzosin
Chemical_Formula
C19H27N5O4
Alfuzosin
RX_link
http://www.rxlist.com/cgi/generic3/uroxatral.htm
Alfuzosin
fda sheet
Alfuzosin
msds (material safety sheet)
Alfuzosin
Synthesis Reference
No information avaliable
Alfuzosin
Molecular Weight
389.449 g/mol
Alfuzosin
Melting Point
No information avaliable
Alfuzosin
H2O Solubility
No information avaliable
Alfuzosin
State
Solid
Alfuzosin
LogP
1.604
Alfuzosin
Dosage Forms
Tablet (extended-release)
Alfuzosin
Indication
For the treatment of the signs and symptoms of benign prostatic hyperplasia.
Alfuzosin
Pharmacology
Alfuzosin is an alpha-adrenergic blocking agent used to treat hypertension and benign prostatic hyperplasia. Accordingly, alfuzosin is a selective inhibitor of the alpha1 subtype of alpha adrenergic receptors. In the human prostate, alfuzosin antagonizes phenylephrine (alpha1 agonist)-induced contractions, in vitro, and binds with high affinity to the alpha1c adrenoceptor, which is thought to be the predominant functional type in the prostate. Studies in normal human subjects have shown that alfuzosin competitively antagonized the pressor effects of phenylephrine (an alpha1 agonist) and the systolic pressor effect of norepinephrine. The antihypertensive effect of alfuzosin results from a decrease in systemic vascular resistance and the parent compound alfuzosin is primarily responsible for the antihypertensive activity.
Alfuzosin
Absorption
Absorption is 50% lower under fasting conditions
Alfuzosin
side effects and Toxicity
side effects are dizziness (due to postural hypotension), upper respiratory tract infection, headache, and fatigue.
Alfuzosin
Patient Information
PATIENT INFORMATION
Follow the links
http://www.rxlist.com/cgi/generic3/uroxatral_pi.htm
http://www.rxlist.com/cgi/generic3/uroxatral_wcp.htm
http://www.drugs.com/cons/Alfuzosin.html
Alfuzosin
Organisms Affected
Humans and other mammals